Cargando…

The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells

The inhibition of the G protein-coupled estrogen receptor (GPER) offers promising perspectives for the treatment of breast tumors. A peptide corresponding to part of the hinge region/AF2 domain of the human estrogen receptor α (ERα17p, residues 295–311) exerts anti-proliferative effects in various b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lappano, Rosamaria, Mallet, Christophe, Rizzuti, Bruno, Grande, Fedora, Galli, Giulia Raffaella, Byrne, Cillian, Broutin, Isabelle, Boudieu, Ludivine, Eschalier, Alain, Jacquot, Yves, Maggiolini, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627388/ https://www.ncbi.nlm.nih.gov/pubmed/31207943 http://dx.doi.org/10.3390/cells8060590

Ejemplares similares

Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
por: Kampa, Marilena, et al.
Publicado: (2023)

The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice
por: Mallet, Christophe, et al.
Publicado: (2021)

Computational Approaches for the Discovery of GPER Targeting Compounds
por: Grande, Fedora, et al.
Publicado: (2020)

AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs)
por: Cirillo, Francesca, et al.
Publicado: (2019)

GPER Function in Breast Cancer: An Overview
por: Lappano, Rosamaria, et al.
Publicado: (2014)

Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology
por: Trichet, Michaël, et al.
Publicado: (2020)

Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action
por: Jouffre, Baptiste, et al.
Publicado: (2023)

GPCR Modulation in Breast Cancer
por: Lappano, Rosamaria, et al.
Publicado: (2018)

MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
por: Lappano, Rosamaria, et al.
Publicado: (2012)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)

HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
por: De Francesco, Ernestina Marianna, et al.
Publicado: (2013)

GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression
por: Santolla, Maria Francesca, et al.
Publicado: (2019)

miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)
por: Vivacqua, Adele, et al.
Publicado: (2018)

The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis
por: Talia, Marianna, et al.
Publicado: (2020)

Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts
por: Pupo, Marco, et al.
Publicado: (2012)

Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2015)

GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2015)

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022)

GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer
por: Cirillo, Francesca, et al.
Publicado: (2017)

A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models
por: Lappano, Rosamaria, et al.
Publicado: (2015)

SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
por: Santolla, M F, et al.
Publicado: (2015)

Editorial: GPER and Human Pathologies
por: Jacquot, Yves, et al.
Publicado: (2021)

Editorial: GPER: Control and Functions
por: Jacquot, Yves, et al.
Publicado: (2021)

GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response
por: De Marco, Paola, et al.
Publicado: (2016)

Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives
por: Lappano, Rosamaria, et al.
Publicado: (2023)

Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells
por: Avino, Silvia, et al.
Publicado: (2016)

Response to “Comment on ‘Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts’”
por: Lappano, Rosamaria, et al.
Publicado: (2016)

Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative Effects
por: Grande, Fedora, et al.
Publicado: (2021)

Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes
por: Rago, Vittoria, et al.
Publicado: (2011)

Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

GPER Mediates Cardiotropic Effects in Spontaneously Hypertensive Rat Hearts
por: De Francesco, Ernestina Marianna, et al.
Publicado: (2013)

GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma
por: Gallo Cantafio, Maria Eugenia, et al.
Publicado: (2023)

The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice
por: Lamoine, Sylvain, et al.
Publicado: (2021)

GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway
por: Cirillo, Francesca, et al.
Publicado: (2023)

Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells
por: Iacopetta, Domenico, et al.
Publicado: (2020)

The lauric acid-activated signaling prompts apoptosis in cancer cells
por: Lappano, Rosamaria, et al.
Publicado: (2017)

The Physiopathological Role of the Exchangers Belonging to the SLC37 Family
por: Cappello, Anna Rita, et al.
Publicado: (2018)

NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer
por: Meng, Ran, et al.
Publicado: (2016)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)
por: Vivacqua, Adele, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_einnlcg80361rsn78jk8bshd00